ÂÜÀòÂÒÂ×

Amanda Bower is an experienced professional in quality control and analytical development, currently serving as Director at Esperion since August 2022. Prior roles include Director and Associate Director of Analytical Chemistry at Venatorx Pharmaceuticals, where responsibilities encompassed collaboration with external vendors for analytical methodologies. Amanda’s tenure at GSK as the analytical lead involved managing technology transfers for late-phase biological drug candidates, ensuring compliance and timely submissions. Earlier experiences at Shire encompassed quality assurance and analytical support roles, along with significant analytical work at Lancaster Laboratories. Educational qualifications include a Master of Science in Regulatory Affairs and Quality Assurance from Temple University and a Bachelor of Science in Biology/Chemistry from Lock Haven University.